Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.

Why is Allarity Therapeutics (ALLR) stock down 23% today?

Source: iQoncept / Shutterstock

Allarity Therapeutics (NASDAQ:ALLR) the stock fell on Friday after the announcement of a reverse stock split.

According to a press release, the company plans to implement a 1 for 35 stock split. This split will become effective today shortly after the market closes. This will see the shares trade on an adjusted post-split basis when markets open on Monday.

Allarity Therapeutics notes that its shares will continue to trade under the ticker symbol ALLR after the reverse split. He also mentions that the new CUSIP number for his shares will be “016744203”.

Why is ALLR stock getting a reverse split?

Allarity Therapeutics conducts a stock split to increase the price of its shares. The company is doing this to regain compliance with the Nasdaq Exchange’s $1 minimum listing rule. Shares of ALLR closed Thursday at $0.113.

ALLR shareholders approved the reverse split at a special meeting of shareholders on March 20. This allowed the company’s board to adopt a split at a ratio between 1:20 and 1:35.

Although a stock split does not change a company’s market capitalization, it does sometimes hurt a stock. Reverse stock splits don’t always inspire confidence in traders, which can lead to declines as ALLR is seeing today.

ALLR stock is down 23.3% on Friday morning.

Investors looking for the latest stock market news will want to keep reading!

InvestorPlace has all the hottest stock market news traders need to know on Friday! This understands why the shares of BGSF (NYSE:BGSF), world bird (NYSE:BRDS), And Therapeutic dermatology (NASDAQ:ARMD) stocks are moving today. You can read more about these questions in the links below!

More Friday stock market news

As of the date of publication, William White had (neither directly nor indirectly) any position in the securities mentioned in this article. The opinions expressed in this article are those of the author, subject to InvestorPlace.com publishing guidelines.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button